Literature DB >> 10063932

Autoantibodies to molecular targets in neutrophils in patients with ulcerative colitis.

J Brimnes1, O H Nielsen, A Wiik, N H Heegaard.   

Abstract

Autoantibodies against neutrophil granulocytes are frequently observed in patients with ulcerative colitis, but a precise description of the autoantigens involved is lacking. Therefore, sera from 75 patients with ulcerative colitis were studied for antibody specificities by means of indirect immunofluorescence microscopy, enzyme-linked immunosorbent assays, and immunoblotting of extracts of neutrophils, neutrophil granules and lymphocytes. Fifty-six percent of the sera reacted in indirect immunofluorescence with ethanol-fixed neutrophils. On formalin-fixed cells most sera shifted fluorescence pattern, indicating a cytoplasmic origin of antigen(s). Only a few sera reacted with specific, known antigens. Immunoblots showed reactions with a broad panel of antigens with preferences for proteins around 55-65 kDa, which were present in azurophilic granules and in cytosol, an 80-kDa protein found in the specific granules, and a 110-kDa unknown cytosol component. In conclusion, neutrophil-specific IgG autoantibodies from ulcerative colitis patients react with several different antigens, most of which are of nonnuclear origin.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10063932     DOI: 10.1023/a:1026683224057

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  31 in total

1.  AN ANTINUCLEAR FACTOR SPECIFIC FOR LEUCOCYTES.

Authors:  V FABER; P ELLING; G NORUP; B MANSA; N I NISSEN
Journal:  Lancet       Date:  1964-08-15       Impact factor: 79.321

2.  Anti-neutrophil cytoplasmic antibodies (ANCA) in ulcerative colitis: anti-cathepsin G and a novel antibody correlate with a refractory type.

Authors:  J Sobajima; S Ozaki; T Okazaki; F Osakada; S Sumita; K Mori; K Nakao
Journal:  Clin Exp Immunol       Date:  1996-07       Impact factor: 4.330

Review 3.  Granulocyte-specific antinuclear antibodies. Possible significance for the pathogenesis, clinical features and diagnosis of rheumatoid arthritis.

Authors:  A Wiik
Journal:  Allergy       Date:  1980-06       Impact factor: 13.146

Review 4.  Antineutrophil cytoplasmic autoantibodies: a review of the antigens involved, the assays, and the clinical and possible pathogenetic consequences.

Authors:  E C Hagen; B E Ballieux; L A van Es; M R Daha; F J van der Woude
Journal:  Blood       Date:  1993-04-15       Impact factor: 22.113

5.  Neutrophil cytoplasmic antibodies (p-ANCA) in ulcerative colitis.

Authors:  P M Ellerbroek; M Oudkerk Pool; B U Ridwan; K M Dolman; B M von Blomberg; A E von dem Borne; S G Meuwissen; R Goldschmeding
Journal:  J Clin Pathol       Date:  1994-03       Impact factor: 3.411

6.  Serum antibodies to Bacteroides species in chronic inflammatory bowel disease.

Authors:  M Tvede; S Bondesen; O H Nielsen; S N Rasmussen
Journal:  Scand J Gastroenterol       Date:  1983-09       Impact factor: 2.423

7.  Anti-neutrophil cytoplasmic antibodies (ANCA) in inflammatory bowel disease: characterization and clinical correlates.

Authors:  A H Mulder; J Broekroelofs; G Horst; P C Limburg; G F Nelis; C G Kallenberg
Journal:  Clin Exp Immunol       Date:  1994-03       Impact factor: 4.330

8.  The ontogeny of a 57-Kd cationic antimicrobial protein of human polymorphonuclear leukocytes: localization to a novel granule population.

Authors:  H A Pereira; J K Spitznagel; E F Winton; W M Shafer; L E Martin; G S Guzman; J Pohl; R W Scott; M N Marra; J M Kinkade
Journal:  Blood       Date:  1990-08-15       Impact factor: 22.113

9.  Anti-neutrophil cytoplasmic antibodies (ANCA) directed against bactericidal/permeability increasing protein (BPI): a new seromarker for inflammatory bowel disease and associated disorders.

Authors:  M P Stoffel; E Csernok; C Herzberg; T Johnson; S F Carroll; W L Gross
Journal:  Clin Exp Immunol       Date:  1996-04       Impact factor: 4.330

10.  Anti-neutrophil cytoplasm antibodies in Wegener's granulomatosis recognize an elastinolytic enzyme.

Authors:  J Lüdemann; B Utecht; W L Gross
Journal:  J Exp Med       Date:  1990-01-01       Impact factor: 14.307

View more
  6 in total

Review 1.  Methods for the detection of anti-neutrophil cytoplasmic antibodies. Recommendations for clinical use of ANCA serology and laboratory efforts to optimize the informative value of ANCA test results.

Authors:  A Wiik
Journal:  Springer Semin Immunopathol       Date:  2001

2.  A prospective study of vasculitis patients collected in a five year period: evaluation of the Chapel Hill nomenclature.

Authors:  S F Sørensen; O Slot; N Tvede; J Petersen
Journal:  Ann Rheum Dis       Date:  2000-06       Impact factor: 19.103

Review 3.  Evaluation of inflammatory activity in Crohn's disease and ulcerative colitis.

Authors:  Eduardo Garcia Vilela; Henrique Osvaldo da Gama Torres; Fabiana Paiva Martins; Maria de Lourdes de Abreu Ferrari; Marcella Menezes Andrade; Aloísio Sales da Cunha
Journal:  World J Gastroenterol       Date:  2012-03-07       Impact factor: 5.742

Review 4.  Autoantibodies in primary sclerosing cholangitis.

Authors:  Johannes-Roksund Hov; Kirsten-Muri Boberg; Tom-H Karlsen
Journal:  World J Gastroenterol       Date:  2008-06-28       Impact factor: 5.742

5.  Characterisation of autoantibodies to neutrophil granule constituents among patients with reactive arthritis, rheumatoid arthritis, and ulcerative colitis.

Authors:  H Locht; T Skogh; A Wiik
Journal:  Ann Rheum Dis       Date:  2000-11       Impact factor: 19.103

6.  High prevalence of autoantibodies among Danish centenarians.

Authors:  K Andersen-Ranberg; M HØier-Madsen; A Wiik; B Jeune; L Hegedus
Journal:  Clin Exp Immunol       Date:  2004-10       Impact factor: 4.330

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.